Stocks
BioMarin Pharmaceutical (BMRN) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | ||||
| Debt/EBITDA | 1.36 | -1.26 | -0.78 | 0.19 | 0.00 | ||||
| Changes by years, y/y, % | -181% | -100% | -38% | -125% | -40.2% | ||||
BioMarin Pharmaceutical. Debt/EBITDA
BioMarin Pharmaceutical. Debt/EBITDA, changes, %
BioMarin Pharmaceutical (BMRN) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 0.15 | 0.12 | -0.30 | -2.94 | -0.65 | 0.00 | ||
| Changes by years, y/y, % | -141% | -134% | -29% | +1 751% | +307% | |||
| Changes by quarters, q/q, % | +227% | -18% | -344% | +895% | -78% | |||
